(Circulation. 1996;94:1726-1732.)
© 1996 American Heart Association, Inc.
Articles |
Pharmacological Stress Thallium Scintigraphy With 2-Cyclohexylmethylidenehydrazinoadenosine (WRC-0470)
A Novel, Short-Acting Adenosine A2A Receptor Agonist
the Cardiovascular Division, Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, and Discovery Therapeutics, Inc (R.J.B.), Richmond, Va.
Correspondence to David K. Glover, ME, University of Virginia Health Sciences Center, Box 500, Health Sciences Center, Charlottesville, VA 22908. E-mail dkg2w@virginia.edu.
Background Pharmacological stress imaging with adenosine or dipyridamole is associated with a high incidence of side effects, including hypotension, chest pain, AV conduction abnormalities, and bronchospasm. Although the desired coronary vasodilatory response is mediated primarily by the adenosine A2A receptors, these side effects result from stimulation of the A1, A2B, or A3 adenosine receptors. We hypothesized that a selective adenosine A2A receptor agonist would induce coronary vasodilatation appropriate for pharmacological stress imaging, without evoking adenosine receptor–mediated side effects.
Methods and Results Infusions of a potent and selective A2A adenosine receptor agonist, WRC-0470 (0.1 to 3 µg · kg-1 ·min-1 for 10 minutes), to five open-chest dogs produced dose-related left anterior descending (LAD) and left circumflex (LCx) coronary artery vasodilatation without altering mean arterial pressure, heart rate, left atrial pressure, or left ventricular dP/dt. In the same dogs, adenosine (300 µg · kg-1 · min-1 for 4 minutes) produced coronary vasodilatation that was limited by significant hypotension. To determine the utility of WRC-0470 for pharmacological stress imaging, the hemodynamic responses to WRC-0470 (0.6 µg · kg-1 · min-1 for 10 minutes) and adenosine (250 µg · kg-1 · min-1 for 4 minutes) were compared in dogs with critical LAD stenoses. 201Tl was injected at the peak WRC-0470 stress response. WRC-0470 increased LCx flow nearly fivefold but did not significantly lower mean arterial pressure. Anteroseptal defects were readily apparent in slice images from all dogs. The mean defect ratio (LAD/LCx) was 0.59±0.06.
Conclusions The potent A2A-selective adenosine receptor agonist WRC-0470 is a short-acting coronary vasodilator with potential utility for pharmacological stress perfusion imaging.
Key Words: adenosine • receptors • radioisotopes • imaging
This article has been cited by other articles:
 |
|
 |
|
  J. E. Udelson, G. V. Heller, F. J.Th. Wackers, A. Chai, D. Hinchman, P. S. Coleman, V. Dilsizian, M. DiCarli, R. Hachamovitch, J. R. Johnson, et al. Randomized, Controlled Dose-Ranging Study of the Selective Adenosine A2A Receptor Agonist Binodenoson for Pharmacological Stress as an Adjunct to Myocardial Perfusion Imaging Circulation, February 3, 2004; 109(4): 457 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N K Sabharwal and A Lahiri Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease Heart, November 1, 2003; 89(11): 1291 - 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Zhao, A. Linke, X. Xu, M. Ochoa, F. Belloni, L. Belardinelli, and T. H. Hintze Comparative Profile of Vasodilation by CVT-3146, a Novel A2A Receptor Agonist, and Adenosine in Conscious Dogs J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 182 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Riou, S. Unger, M.-C. Toufektsian, M. Ruiz, D. D. Watson, G. A. Beller, and D. K. Glover Effects of Increased Lipid Concentration and Hyperemic Blood Flow on the Intrinsic Myocardial Washout Kinetics of 99mTcN-NOET J. Nucl. Med., July 1, 2003; 44(7): 1092 - 1098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Kearney, K. A. A. Fox, A. J. Lee, R. J. Prescott, A. M. Shah, P. D. Batin, W. Baig, S. Lindsay, T. S. Callahan, W. E. Shell, et al. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1801 - 1808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Riou, M. Ruiz, G. W. Sullivan, J. Linden, H. Leong-Poi, J. R. Lindner, T. D. Harris, G. A. Beller, and D. K. Glover Assessment of Myocardial Inflammation Produced by Experimental Coronary Occlusion and Reperfusion With 99mTc-RP517, a New Leukotriene B4 Receptor Antagonist That Preferentially Labels Neutrophils In Vivo Circulation, July 30, 2002; 106(5): 592 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Glover, M. Ruiz, K. Takehana, F. D. Petruzella, L. M. Riou, J. M. Rieger, T. L. Macdonald, D. D. Watson, J. Linden, and G. A. Beller Pharmacological Stress Myocardial Perfusion Imaging With the Potent and Selective A2A Adenosine Receptor Agonists ATL193 and ATL146e Administered by Either Intravenous Infusion or Bolus Injection Circulation, September 4, 2001; 104(10): 1181 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Gao, Z. Li, S. P. Baker, R. D. Lasley, S. Meyer, E. Elzein, V. Palle, J. A. Zablocki, B. Blackburn, and L. Belardinelli Novel Short-Acting A2A Adenosine Receptor Agonists for Coronary Vasodilation: Inverse Relationship between Affinity and Duration of Action of A2A Agonists J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 209 - 218. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. K. Hinschen, R. B. Rose'Meyer, and J. P. Headrick Age-related changes in adenosine-mediated relaxation of coronary and aortic smooth muscle Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2380 - H2389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Leistad, K. Ohmori, T. A. Peterson, G. Christensen, and A. N. DeMaria Quantitative assessment of myocardial perfusion during graded coronary artery stenoses by intravenous myocardial contrast echocardiography J. Am. Coll. Cardiol., February 1, 2001; 37(2): 624 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-X. He, E. Cwajg, W. Hwang, C. J. Hartley, E. Funk, L. H. Michael, and M. S. Verani Myocardial Blood Flow and Myocardial Uptake of 201Tl and 99mTc-Sestamibi During Coronary Vasodilation Induced by CGS-21680, a Selective Adenosine A2A Receptor Agonist Circulation, July 25, 2000; 102(4): 438 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Beller and B. L. Zaret Contributions of Nuclear Cardiology to Diagnosis and Prognosis of Patients With Coronary Artery Disease Circulation, March 28, 2000; 101(12): 1465 - 1478. [Full Text] [PDF]
|
|
|
|
|
|
A. R. Jayaweera, K. Wei, M. Coggins, J. P. Bin, C. Goodman, and S. Kaul Role of capillaries in determining CBF reserve: new insights using myocardial contrast echocardiography Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2363 - H2372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Z. Linka, J. Sklenar, K. Wei, A. R. Jayaweera, D. M. Skyba, and S. Kaul Assessment of Transmural Distribution of Myocardial Perfusion With Contrast Echocardiography Circulation, November 3, 1998; 98(18): 1912 - 1920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Shryock, S. Snowdy, P. G. Baraldi, B. Cacciari, G. Spalluto, A. Monopoli, E. Ongini, S. P. Baker, and L. Belardinelli A2A-Adenosine Receptor Reserve for Coronary Vasodilation Circulation, August 18, 1998; 98(7): 711 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wei, A. R. Jayaweera, S. Firoozan, A. Linka, D. M. Skyba, and S. Kaul Quantification of Myocardial Blood Flow With Ultrasound-Induced Destruction of Microbubbles Administered as a Constant Venous Infusion Circulation, February 10, 1998; 97(5): 473 - 483. [Abstract] [Full Text] [PDF]
|
|